Vertex Pharmaceuticals (VRTX) FY Conference June 10, 2025 02:40 PM ET Speaker0 Launch, we are now seeing the building of momentum as we build up that franchise. And then most recently, the launch of Gernavix in acute pain. We're keenly focused on those three launches. As we also think about the next wave of innovation that's either in or nearing Phase III development. There are three actually four programs that are already in Phase III development, and the one, POV in membranous is coming very soon. And the ...